SEARCH

SEARCH BY CITATION

References

  • Benedetti A, Comporti M, Esterbauer H (1980). Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta 620: 281296.
  • Boldogh I, Bacsi A, Choudhury BK, Dharajiya N, Alam R, Hazra TK et al. (2005). ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation. J Clin Invest 115: 21692179.
  • Bowers RC, Hevko J, Henson PM, Murphy RC (2000). A novel glutathione containing eicosanoid (FOG7) chemotactic for human granulocytes. J Biol Chem 275: 2993129934.
  • Cotran RS, Kumar V, Collins T (Eds) (1999). Robbins Pathologic Basis of Disease. Philidelphia: W.B. Saunders.
  • Curzio M, Esterbauer H, Poli G, Biasi F, Cecchini G, Di Mauro C et al. (1987). Possible role of aldehydic lipid peroxidation products as chemoattractants. Int J Tissue React 9: 295306.
  • Dianzani C, Parrini M, Ferrara C, Fantozzi R (1996). Effect of 4-hydroxynonenal on superoxide anion production from primed human neutrophils. Cell Biochem Funct 14: 193200.
  • Falletti O, Cadet J, Favier A, Douki T (2007). Trapping of 4-hydroxynonenal by glutathione efficiently prevents formation of DNA adducts in human cells. Free Radic Biol Med 42: 12581269.
  • Fiore S, Serhan CN (1995). Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction. Biochemistry 34: 1667816686.
  • Fuhrman B, Partoush A, Volkova N, Aviram M (2008). Ox-LDL induces monocyte-to-macrophage differentiation in vivo: Possible role for the macrophage colony stimulating factor receptor (M-CSF-R). Atherosclerosis 196: 598607.
  • Griswold DE, Webb EF, Hillegass LM (1991). Induction of plasma exudation and inflammatory cell infiltration by leukotriene C4 and leukotriene B4 in mouse peritonitis. Inflammation 15: 251258.
  • Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N et al. (2006). RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis. Faseb J 20: 401403.
  • Hong S, Porter TF, Lu Y, Oh SF, Pillai PS, Serhan CN (2008). Resolvin E1 metabolome in local inactivation during inflammation-resolution. J Immunol 180: 35123519.
  • Kasuga K, Yang R, Porter TF, Agrawal N, Petasis NA, Irimia D et al. (2008). Rapid appearance of resolvin precursors in inflammatory exudates: Novel mechanisms in resolution. J Immunol 181: 86778687.
  • Kuiper HC, Miranda CL, Sowell JD, Stevens JF (2008). Mercapturic acid conjugates of 4-hydroxy-2-nonenal and 4-oxo-2-nonenal metabolites are in vivo markers of oxidative stress. J Biol Chem 283: 1713117138.
  • Lehr HA, Hubner C, Finckh B, Angermuller S, Nolte D, Beisiegel U et al. (1991). Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters. J Clin Invest 88: 914.
  • Libby P (2007). Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 65: S140S146.
  • Maeba R, Maruyama A, Tarutani O, Ueta N, Shimasaki H (1995). Oxidized low-density lipoprotein induces the production of superoxide by neutrophils. FEBS Lett 377: 309312.
  • Milne GL, Zanoni G, Porta A, Sasi S, Vidari G, Musiek ES et al. (2004). The cyclopentenone product of lipid peroxidation, 15-A2t-isoprostane, is efficiently metabolized by HepG2 cells via conjugation with glutathione. Chem Res Toxicol 17: 1725.
  • Molad Y, Haines KA, Anderson DC, Buyon JP, Cronstein BN (1994). Immunocomplexes stimulate different signalling events to chemoattractants in the neutrophil and regulate L-selectin and beta 2-integrin expression differently. Biochem J 299 (Pt 3): 881887.
  • Ramana KV, Bhatnagar A, Srivastava S, Yadav UC, Awasthi S, Awasthi YC et al. (2006). Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth. J Biol Chem 281: 1765217660.
  • Rathahao E, Peiro G, Martins N, Alary J, Gueraud F, Debrauwer L (2005). Liquid chromatography-multistage tandem mass spectrometry for the quantification of dihydroxynonene mercapturic acid (DHN-MA), a urinary end-metabolite of 4-hydroxynonenal. Anal Bioanal Chem 381: 15321539.
  • Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN (1987). Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237: 11711176.
  • Schaur RJ, Dussing G, Kink E, Schauenstein E, Posch W, Kukovetz E et al. (1994). The lipid peroxidation product 4-hydroxynonenal is formed by–and is able to attract–rat neutrophils in vivo. Free Radic Res 20: 365373.
  • Selley ML, Bourne DJ, Bartlett MR, Tymms KE, Brook AS, Duffield AM et al. (1992). Occurrence of (E)-4-hydroxy-2-nonenal in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 51: 481484.
  • Serhan CN, Chiang N (2008). Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Br J Pharmacol 153 (Suppl. 1): S200S215.
  • Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G et al. (2002). Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196: 10251037.
  • Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'neill LA et al. (2007a). Resolution of inflammation: state of the art, definitions and terms. Faseb J 21: 325332.
  • Serhan CN, Lu Y, Hong S, Yang R (2007b). Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins. Methods Enzymol 432: 275317.
  • Siems W, Grune T (2003). Intracellular metabolism of 4-hydroxynonenal. Mol Aspects Med 24: 167175.
  • Siems WG, Zollner H, Grune T, Esterbauer H (1997). Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product. J Lipid Res 38: 612622.
  • Srivastava S, Chandra A, Wang LF, Seifert WE Jr, Dague BB, Ansari NH et al. (1998). Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J Biol Chem 273: 1089310900.
  • Srivastava S, Conklin DJ, Liu SQ, Prakash N, Boor PJ, Srivastava SK et al. (2001). Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells. Atherosclerosis 158: 339350.
  • Srivastava S, Dixit BL, Cai J, Sharma S, Hurst HE, Bhatnagar A et al. (2000). Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: role of aldose reductase. Free Radic Biol Med 29: 642651.
  • Strohmaier H, Hinghofer-Szalkay H, Schaur RJ (1995). Detection of 4-hydroxynonenal (HNE) as a physiological component in human plasma. J Lipid Mediat Cell Signal 11: 5161.
  • Subbanagounder G, Watson AD, Berliner JA (2000). Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities. Free Radic Biol Med 28: 17511761.
  • Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E et al. (2007). Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 282: 93239334.
  • Volkel W, Alvarez-Sanchez R, Weick I, Mally A, Dekant W, Pahler A (2005). Glutathione conjugates of 4-hydroxy-2(E)-nonenal as biomarkers of hepatic oxidative stress-induced lipid peroxidation in rats. Free Radic Biol Med 38: 15261536.
  • Volkel W, Sicilia T, Pahler A, Gsell W, Tatschner T, Jellinger K et al. (2006). Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease. Neurochem Int 48: 679686.
  • Winyard PG, Willoughby DA (Eds) (2003). Inflammation Protocols. Totowa, NJ: Humana Press.
  • Xie C, Lovell MA, Markesbery WR (1998). Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity. Free Radic Biol Med 25: 979988.
  • Yavin E, Brand A, Green P (2002). Docosahexaenoic acid abundance in the brain: a biodevice to combat oxidative stress. Nutr Neurosci 5: 149157.
  • Yedgar S, Krimsky M, Cohen Y, Flower RJ (2007). Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword? Trends Pharmacol Sci 28: 459464.
  • Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S et al. (1989). Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84: 10861095.